Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
July 03, 2026 by reason.org
Southern California’s total tobacco bans aren’t helping public health
Southern California’s total tobacco bans raise serious questions about whether prohibition is improving public health or simply shifting behaviour elsewhere. When legal access is removed, consumers may turn to neighbouring markets, illicit sellers or more harmful products that remain easier to obtain. Policies aimed at reducing harm should be judged by real-world outcomes, not symbolic restrictions. Effective regulation should protect young people while preserving realistic pathways away from combustible tobacco.
July 02, 2026 by realclearscience.com
On Nicotine, FDA Embraces Science and Delivers a Public Health Victory
The FDA’s authorisation of modified risk claims for ZYN nicotine pouches marks a public health win for evidence-based risk communication. It recognises a simple but often ignored fact: smoke-free nicotine products do not carry the same risks as combustible cigarettes. For adult smokers, clear information about lower-risk alternatives can support better decisions and more realistic routes away from smoking. Public health should follow the science, not blur all nicotine products into the same category.
July 01, 2026 by reuters.com
FDA allows Philip Morris to market Zyn as less harmful than cigarettes
The FDA’s decision to allow ZYN nicotine pouches to be marketed as less harmful than cigarettes is a major moment for relative-risk communication. The agency has authorised claims for 20 ZYN products, recognising that switching completely from smoking to these smoke-free alternatives can reduce the risk of several serious diseases. For adult smokers, clear information matters: not all nicotine products carry the same level of harm. Public health should make evidence-based switching messages easier to understand, not harder to hear.
July 01, 2026 by fda.gov
FDA Authorizes 20 ZYN Nicotine Pouches to Be Marketed with Specific Modified Risk Claim
The FDA’s authorisation of modified risk claims for 20 ZYN nicotine pouch products marks an important step for evidence-based nicotine communication. Adults who smoke should be able to receive clear information that switching completely from cigarettes to authorised smoke-free products can reduce specific disease risks. The decision recognises that not all nicotine products carry the same harm, and that accurate relative-risk messaging can support better choices. Public health should make lower-risk information visible, not harder to say.
June 30, 2026 by regulatorwatch.com
Battleground Vape | U.S. Vaping Industry Continues Court Fight | RegWatch
The US vape court battles show how contested the future of harm reduction has become. While cigarettes remain widely available, regulated vaping products face years of legal uncertainty, approval delays and enforcement disputes. For adult smokers, that means fewer reliable routes away from combustible tobacco. Public health policy should protect young people without keeping lower-risk alternatives trapped in a regulatory battleground.
June 30, 2026 by regulatorwatch.com
Battleground Vape | U.S. Vaping Industry Continues Court Fight | RegWatch
The US vape court battles show how contested the future of harm reduction has become. While cigarettes remain widely available, regulated vaping products face years of legal uncertainty, approval delays and enforcement disputes. For adult smokers, that means fewer reliable routes away from combustible tobacco. Public health policy should protect young people without keeping lower-risk alternatives trapped in a regulatory battleground.
June 29, 2026 by clearingtheair.eu
Vape flavour restrictions could weaken smoking quit attempts, studies suggest
Vape flavour restrictions may weaken quit attempts by making lower-risk alternatives less appealing to adult smokers. Flavours can help people move away from the taste and ritual of cigarettes, supporting a clearer break from combustible tobacco. Protecting young people is essential, but broad flavour bans risk removing one of the tools that helps smokers switch. Evidence-based policy should target youth access without undermining adult cessation.
June 24, 2026 by reason.com
Secret Emails Reveal Sketchy Tactics in California Public Health's Tobacco Ban 'Endgame'
Public records from California raise troubling questions about how tobacco “endgame” policies are being advanced. When health agencies and funded partners coordinate messaging, polling and local campaigns behind the scenes, public consultation risks becoming political theatre rather than genuine debate. Tobacco policy should be transparent, evidence-based and accountable to the communities it affects. Public health loses trust when outcomes appear to be managed before the public has been heard.
June 24, 2026 by regulatorwatch.com
Where’s the Outrage? | Lack of Urgency Mires U.S. Nicotine Industry | RegWatch
The lack of urgency in US nicotine regulation is leaving adult smokers with fewer legal, lower-risk options while cigarettes remain widely available. Delays, uncertainty and uneven enforcement weaken the regulated market and create space for illicit products to grow. Harm reduction cannot work if safer alternatives are trapped in regulatory limbo. Public health should move faster to support products that help people leave combustion behind.
June 24, 2026 by regulatorwatch.com
Where’s the Outrage? | Lack of Urgency Mires U.S. Nicotine Industry | RegWatch
The lack of urgency in US nicotine regulation is leaving adult smokers with fewer legal, lower-risk options while cigarettes remain widely available. Delays, uncertainty and uneven enforcement weaken the regulated market and create space for illicit products to grow. Harm reduction cannot work if safer alternatives are trapped in regulatory limbo. Public health should move faster to support products that help people leave combustion behind.
RELATED VIDEOS
RELATED VIDEOS
24 July 2024
US Cigarette Market is declining!
12 June 2020
2. Greg Conley | USA | - Powerful forces not always benign
19 May 2025
Tobacco Harm Reduction is progressing in the US!
29 June 2017
Legal remedies in the US - Challenging the FDA. Patricia Kovacevic
07 November 2023
FDA vs FLAVOURS | Will Godfrey explores the battle over flavours in the USA | #GFNNews
18 October 2024
NICOTINE POUCHES UNDER THREAT | Maria Papaioannoy joins us for part 2 of our Canada special
06 September 2019
USA regulation of ENDS
26 March 2024
WHAT'S THE FUSS OVER ZYN? | Cullip tackles the rise of nicotine pouches in the USA | #GFNNews